Serum Institute of India to Conduct Clinical Trials of Novavax Vaccine for Children: Report

New Delhi: The Serum Institute of India (SII) is planning to conduct clinical trials of Novavax vaccine for children in July, according to media report.
The US-based biotechnology company
Novavax, one of the leading biotechnology companies in the US, has teamed up with the SII to manufacture its Covid-19 vaccine, Covovax.

According to Novavax, its nano-particle protein-based vaccine has demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials.